Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer.
释放利戈塞替尼作为卵巢癌选择性疗法的治疗潜力
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102218
Nath Shalini, Claridge Sally, Granados Genesis Lara, Al Assaad Majd, Park Eric, Cavallo Julie-Ann, Nuwere Ufuoma, Ackon Maame Esi, De Boni Lamberto, Baker Stacey, Reddy E Premkumar, Blank Stephanie V, Elemento Olivier, Brody Rachel, Hopkins Benjamin D
